Condition: Depression, Anxiety · Antenatal Depression · Postnatal Depression · Sponsor: Kenyatta National Hospital
Perinatal mood and anxiety disorders (PMAD), defined as depression and anxiety during pregnancy or up to 1 year postpartum, account for substantial morbidity and mortality among birthing people globally especially in low- and middle-income countries. Several evidence-based interventions are recommended for identification and management of PMAD by non-specialist providers in resource-limited settings. This cluster-randomized trial seeks to evaluate the effect of a stepped-care intervention for screening and treatment of PMAD among perinatal women, on clinical and implementation outcomes.
This description comes directly from the study's public registry record.
Nancy Ngumbau, MBChB, MPH · +254713917226 · nancym390@gmail.com
Agnes Karume, MBChB, MPH · +254715181283 · karumeagnes@gmail.com
Always discuss trial participation with your own doctor first.
| Kenyatta National Hospital | Nairobi, Kenya | Recruiting |
| HomaBay, Siaya and Kisumu | Western Kenya, Kenya | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06456307